A joint initiative to understand blood generation in health and disease
- Hemato-Linné is an excellence research environment in hematopoiesis at Lund University.
- Financed by the Swedish Research Council through a 10-year Linnaeus grant, Hemato-Linné was established in 2006 as a world-leading research environment to study the regulation of normal and leukemic hematopoietic stem cells and blood lineage development.
- Hemato-Linné also focuses on excellence in research training and career development of young scientists.
The Division of Molecular Medicine and Gene Therapy turns 20 years and we therefore take pleasure in announcing a symposium in honor of Stefan Karlsson. Stefan founded the Division in 1995 and has since then been the driving force in establishing the strong hematopoiesis environment at Lund University.
Venue: Belfrage Lecture hall, BMC D15, Klinikgatan 32
Date and time: May 15th at 13.00 - 16.30
Congratulations to HematoLinné PI Johan Flygare, who was awarded funding from The Diamond Blackfan Anemia Foundation (DBAF) and Diamond Blackfan Anemia Canada (DBAC) to continue his research on the development of safer and more potent drugs to treat DBA. Using a chemical screen of 12,000 substances, Dr. Flygare and his team have identified several potential drug targets that showed a therapeutic effect on the formation of red blood cells. They will now focus their efforts on the characterisation of these novel compounds and their therapeutic mechanisms.
Professor Ross Hannan from John Curtin School of Medical Research, Australian National University, Canberra, Australia, will be visiting Lund on May 7-8.
He will give a lecture entitled: ”Nucleolar stress: A paradigm that underlies hematologic disease” on Thursday May 7 at 14:00 in Segerfalk lecture hall, BMC A10.
Host: Johan Flygare
This seminar is sponsored by StemTherapy.
Unistem Day 2015 at Lund Stem Cell Center has been a great success! Approximately 200 high school students visited Lund Stem Cell Center on March 13th 2015 to listen to lectures about stem cells and to gain insight into the daily work of scientists through multiple hands-on sessions and workshops.
Read more about the event here:
Congratulations to Jonas Larsson who was recently awarded an ERC Consolidator Grant. Of the 2,525 applications received from all over Europe, 372 were awarded funding. Jonas Larsson is one out of nine Swedish researchers who received an ERC Consolidator Grant 2014. He was awarded € 2 million for his research on "Uncovering Targets for Ex Vivo Expansion of Hematopoietic Stem Cells to Enhance Cell Therapies of Blood Disorders (UNEXPECTED)".